0.4935
-0.0365
(-6.89%)
At close: April 15 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.14 | -0.12 | -0.52 | -0.59 |
| Low Estimate | -0.17 | -0.13 | -0.57 | -0.86 |
| High Estimate | -0.13 | -0.11 | -0.48 | -0.41 |
| Year Ago EPS | -0.17 | -0.15 | -0.5 | -0.52 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | 4.3M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 7.9M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.22 | -0.2 | -0.2 | -0.16 |
| EPS Actual | -0.17 | -0.15 | -0.13 | -0.07 |
| Difference | 0.05 | 0.05 | 0.07 | 0.09 |
| Surprise % | 21.02% | 26.23% | 33.90% | 56.25% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.14 | -0.12 | -0.52 | -0.59 |
| 7 Days Ago | -0.15 | -0.13 | -0.52 | -0.64 |
| 30 Days Ago | -0.19 | -0.2 | -0.71 | -0.72 |
| 60 Days Ago | -0.19 | -0.2 | -0.71 | -0.72 |
| 90 Days Ago | -0.19 | -0.2 | -0.71 | -0.72 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TLPH | 15.59% | 17.78% | -3.33% | -14.19% |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/1/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/21/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/16/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/15/2024 |
| Initiated | Maxim Group: Buy | 5/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/7/2024 |
Related Tickers
TNPH Tian'an Pharmaceutical Co., Ltd.
0.0020
0.00%
CTOR Citius Oncology, Inc.
0.6830
+2.89%
AYTU Aytu BioPharma, Inc.
1.0400
+2.97%
THCT THC Therapeutics, Inc.
0.0004
0.00%
TXMD TherapeuticsMD, Inc.
1.0400
+0.97%
BFRI Biofrontera Inc.
0.8559
+6.85%
SFZN.SW Siegfried Holding AG
886.00
+0.11%
MYCOF Mydecine Innovations Group Inc.
0.0030
0.00%
LFSWF Lifeist Wellness Inc.
0.0270
+8.00%
RMTI Rockwell Medical, Inc.
1.0400
-0.48%